Broad‐Spectrum Antibacterial Activity of Postbiotic From Lacticaseibacillus paracasei BGP1 Against Multidrug‐Resistant Skin Wound Pathogens
MicrobiologyOpen · 2025-12 · 14 (6)
DOI: 10.1002/mbo3.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 08.12.2025. Verfasst von Farideh Mohammadhosseinzadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Probiotics, Wound Infection. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
The increasing problem of antibiotic resistance indicates the need for alternative therapeutic strategies for skin wound infections. While probiotics exhibit potential for developing such alternatives, the majority of antimicrobial studies focus on live cells or lysates and oral delivery. Notably, in dermatology, formulating products with live strains poses technical challenges due to stability issues in water‐based systems. Postbiotics, substances made from probiotics, offer a promising, stable, and safe alternative. This study addresses the gap by evaluating the antibacterial potential of cell‐free supernatants (CFSs) from six probiotic strains, with a specific focus on Lacticaseibacillus paracasei BGP1, against clinically relevant skin pathogens. CFSs were screened in vitro using agar well diffusion and broth microdilution assays against Staphylococcus aureus ATCC 25923, methicillin‐resistant S. aureus (MRSA; UTMC 1442), Pseudomonas aeruginosa ATCC 27853, and P. aeruginosa PAO1. GC‐MS analysis was used to identify bioactive compounds in the most promising CFS. Among the tested strains, BGP1 demonstrated both consistent inhibitory (MIC: 6.25 mg/mL) and bactericidal (MBC: 12.5 mg/mL) effects. GC‐MS analysis identified palmitic acid (33.24%) and stearic acid (46.45%) as dominant bioactive compounds. These findings provide novel evidence that postbiotic metabolites from L. paracasei BGP1 represent a promising, broad‐spectrum, stable, and nonliving candidate to conventional therapies for antibiotic‐resistant skin wound infections. Further in vivo research is needed to evaluate their therapeutic potential and formulation in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
- Department of Biology, Faculty of Science, Shahid Bahonar University of Kerman, Kerman, Iran.
- Department of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
ORCID-Profile: Farideh Mohammadhosseinzadeh, Ehsan Arefian, Mouj Khaleghi
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Mohammadhosseinzadeh, F., Arefian, E., Khaleghi, M., Keshmiri Neghab, H., & Kashef, N. (2025). Broad‐Spectrum Antibacterial Activity of Postbiotic From Lacticaseibacillus paracasei BGP1 Against Multidrug‐Resistant Skin Wound Pathogens. MicrobiologyOpen, 14(6). https://doi.org/10.1002/mbo3.70137
Vancouver
Mohammadhosseinzadeh F, Arefian E, Khaleghi M, Keshmiri Neghab H, Kashef N. Broad‐Spectrum Antibacterial Activity of Postbiotic From Lacticaseibacillus paracasei BGP1 Against Multidrug‐Resistant Skin Wound Pathogens. MicrobiologyOpen. 2025;14(6). doi:10.1002/mbo3.70137
BibTeX
@article{Mohammadhosseinzadeh2025,
author = {Mohammadhosseinzadeh, Farideh and Arefian, Ehsan and Khaleghi, Mouj and Keshmiri Neghab, Hoda and Kashef, Nasim},
title = {Broad‐Spectrum Antibacterial Activity of Postbiotic From Lacticaseibacillus paracasei BGP1 Against Multidrug‐Resistant Skin Wound Pathogens},
journal = {MicrobiologyOpen},
year = {2025},
volume = {14},
number = {6},
doi = {10.1002/mbo3.70137}
}
EUVIMED